Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01719211
Other study ID # 1999-p-007948
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 1999
Est. completion date December 2025

Study information

Verified date November 2023
Source Massachusetts General Hospital
Contact Susan Slaugenhaupt, PhD
Phone 6176433217
Email slaugenhaupt@chgr.mgh.harvard.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The investigators have successfully identified two novel genetic loci for MVP on chromosomes 11 and 13 and are searching for altered genes in these regions. This requires recruiting large families who may have MVP linked to these or other chromosomes; and obtaining DNA samples from 1,000-1,500 individually affected patients to study the relation between DNA markers throughout the genome and MVP. It is our expectation that the results of this study will lead to the discovery of gene(s) responsible for MVP. This will lead to improved understanding of the disease and, in turn, improved ability to treat and prevent progression in genetically susceptible individuals.


Description:

This is a genome-wide association study.


Recruitment information / eligibility

Status Recruiting
Enrollment 1500
Est. completion date December 2025
Est. primary completion date December 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Mitral valve prolapse Exclusion Criteria: - Other mitral valve diseases

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Mass General Hospital Boston Massachusetts

Sponsors (2)

Lead Sponsor Collaborator
Massachusetts General Hospital Leducq Foundation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Discovery of the genetic basis of Mitral Valve Prolapse Genome-wide association 5 years
See also
  Status Clinical Trial Phase
Not yet recruiting NCT02499419 - Exercise Capacity Evaluation in Patients With Non-rheumatic Mitral Valve Prolapse (MVP) N/A
Completed NCT02105480 - Automated Algorithm Based Analysis of Phonocardiograms of Newborns
Completed NCT02512341 - Automatic Differentiation of Innocent and Pathologic Murmurs in Pediatrics
Enrolling by invitation NCT04067635 - Primary Mitral Regurgitation Repair
Recruiting NCT06378996 - Arrhythmic Mitral Valve Prolapse Detection Using Long-term Ambulatory Rhythm Monitoring N/A
Terminated NCT03285724 - Safety and Performance Study of the Harpoon Mitral Valve Repair System N/A
Recruiting NCT03506217 - Using Pulse Counter Vigileo-Flotrac System in Transapical Off-pump Minimally Invasive Mitral Valve Repair
Completed NCT00665301 - Cardiac Output Pulmonary Arterial Catheter Compared to FloWaveâ„¢ 1000 N/A
Not yet recruiting NCT04299334 - Neochordae Technique in Mitral Valve Repair Phase 1
Completed NCT03470155 - Operative Mitral Valve Reconstruction in Functional mv Insufficiency With Reduced Systolic Ventricle Function
Recruiting NCT06341166 - Multiparametric SCores for Prediction of Myocardial fIbrosis in Patients With MITral vAlve pRolapse
Completed NCT04231903 - Myocardial Protection in Minimally Invasive Mitral Valve Surgery
Not yet recruiting NCT03609931 - Patient Specific Mitral Valve Modeling for Surgical Planning and Training
Recruiting NCT05631730 - Effect and Safety of Flecainide and Metoprolol Versus Metoprolol Alone to Suppress Ventricular Arrhythmias in Arrhythmic Mitral Valve Prolapse Phase 3
Recruiting NCT02552771 - The Canadian Mitral Research Alliance (CAMRA) Trial CardioLink-2 N/A
Recruiting NCT04190602 - Multicenter Post-Market Observational Registry of the NeoChord Artificial Chordae Delivery System
Recruiting NCT03113552 - Prognostic Impact of the Location of Mitral Valve Prolapse on the Long-term Results of Mitral Plasty
Recruiting NCT06255457 - Ventricular Arrhythmias in Patients Undergoing Mitral Valve Surgery
Completed NCT02771275 - Safety and Early Feasibility Study of the Harpoon Medical Device (EFS) N/A
Recruiting NCT05562804 - Mitral Valve Prolapse, Arrhythmias and Mitral Valve Surgery